ROSSI, COSMO
 Distribuzione geografica
Continente #
NA - Nord America 657
EU - Europa 536
AS - Asia 197
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.393
Nazione #
US - Stati Uniti d'America 656
IT - Italia 172
CN - Cina 102
IE - Irlanda 92
SE - Svezia 83
GB - Regno Unito 52
TR - Turchia 52
UA - Ucraina 50
FR - Francia 34
DE - Germania 28
IN - India 23
VN - Vietnam 13
BE - Belgio 10
FI - Finlandia 9
HK - Hong Kong 4
NL - Olanda 3
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CA - Canada 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
NP - Nepal 1
RO - Romania 1
SG - Singapore 1
Totale 1.393
Città #
Chandler 165
Dublin 92
Jacksonville 80
Ann Arbor 62
Chieti 47
Princeton 41
Dearborn 38
Ashburn 37
Southend 34
Nanjing 30
Izmir 25
Altamura 18
New York 16
Dong Ket 13
Beijing 12
Cambridge 12
Nanchang 12
Brussels 10
Wilmington 10
Jinan 8
Woodbridge 8
Collecorvino 7
Boardman 6
Finale Ligure 5
Milan 5
Norwalk 5
Rome 5
Tianjin 5
Hong Kong 4
Kunming 4
London 4
Shenyang 4
Changsha 3
Hebei 3
Mazara del Vallo 3
Munich 3
Pune 3
Tappahannock 3
Washington 3
Augusta 2
Carini 2
Cattolica 2
Frankfurt am Main 2
Grafing 2
Hangzhou 2
Helsinki 2
Jiaxing 2
L'aquila 2
Orsogna 2
Redwood City 2
Sheffield 2
Shenzhen 2
Siracusa 2
Spoltore 2
Zhengzhou 2
Amsterdam 1
Ardea 1
Bari 1
Borca 1
Budapest 1
Busso 1
Castellamonte 1
Changchun 1
Chaoyang 1
Chengdu 1
Chicago 1
Civitella Del Tronto 1
Clearwater 1
Collegno 1
Corridonia 1
Frascati 1
Fuzhou 1
Gavirate 1
Guangzhou 1
Hefei 1
Houston 1
Jülich 1
Kathmandu 1
Lanzhou 1
Laurel 1
Los Angeles 1
Mcallen 1
Mergo 1
Messina 1
Napoli 1
Ningbo 1
Orlando 1
Pescara 1
Redmond 1
Sansepolcro 1
Santa Clara 1
Seattle 1
Shizuoka 1
Silvi 1
Singapore 1
São Paulo 1
Taizhou 1
Teramo 1
Toronto 1
Tyresö 1
Totale 922
Nome #
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib 163
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 151
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 108
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice 106
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 91
A developmental model of paragangliar tumorigenesis highlights therapeutic targets 85
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 82
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 82
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 81
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 81
Resveratrol has anti-thyroid effects both in vitro and in vivo 80
Prognostic relevance of LGALS3BP in human colorectal carcinoma 80
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 76
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 72
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 62
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 48
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 46
POSTER SESSIONS 35
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 33
Intragastric administration of the monomeric allergoid Par-j1 induces up-regulation of CD4 1 CD25 1 IL-10 1 T regulatory cells (Tregs) in spleen and mesenteric lymph node in sensitized BALB/c mice: 691 15
null 11
Totale 1.588
Categoria #
all - tutte 4.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201950 0 0 0 0 0 0 0 0 0 2 7 41
2019/2020306 54 13 4 4 34 29 45 21 18 55 22 7
2020/2021205 20 3 21 8 14 29 18 10 21 24 12 25
2021/2022158 4 6 5 41 5 10 11 13 7 6 14 36
2022/2023414 35 74 32 56 30 63 17 33 55 4 11 4
2023/2024173 9 8 17 5 11 73 27 16 3 4 0 0
Totale 1.588